120 related articles for article (PubMed ID: 9010562)
41. [A case of kohyamaki pollinosis].
Ashida T; Matsunaga T; Ide T; Tabata S
Arerugi; 1986 Apr; 35(4):245-9. PubMed ID: 2427051
[No Abstract] [Full Text] [Related]
42. Local intranasal immunotherapy with allergen in powder in atopic patients sensitive to Parietaria officinalis pollen.
Ariano R; Panzani RC; Chiapella M; Augeri G; Falagiani P
J Investig Allergol Clin Immunol; 1995; 5(3):126-32. PubMed ID: 7582157
[TBL] [Abstract][Full Text] [Related]
43. Leukocyte histamine release and humoral changes during oral and subcutaneous hyposensitization of grass pollen allergic children.
Wahn U; Maasch HJ; Geissler W
Helv Paediatr Acta; 1984 May; 39(2):137-44. PubMed ID: 6085730
[TBL] [Abstract][Full Text] [Related]
44. The impact of immunotherapy on the pathophysiology of ragweed pollen allergy.
Ford SA; Baroody FM; Naclerio RM
Rhinol Suppl; 1992; 14():52-6. PubMed ID: 1389403
[No Abstract] [Full Text] [Related]
45. Tolerance and immunological changes of chemically modified allergen vaccine of Parietaria judaica in accelerated schedules.
Asturias JA; Ferrer A; Arilla MC; Andreu C; Madariaga B; Martínez A
Clin Exp Immunol; 2007 Mar; 147(3):491-6. PubMed ID: 17302898
[TBL] [Abstract][Full Text] [Related]
46. [Is the diagnostic differentiation between Parietaria officinalis and Parietaria judaica important for the specific immunotherapy?].
Cambri S; Tarantino G; Cambri V
Clin Ter; 1986 Nov; 119(4):269-73. PubMed ID: 3802737
[No Abstract] [Full Text] [Related]
47. Hyposensitization. Comparing a purified (refined) allergen preparation and a crude aqueous extract from timothy pollen.
Frostad AB; Grimmer O; Sandvik L; Aas K
Allergy; 1980 Mar; 35(2):81-95. PubMed ID: 7386802
[TBL] [Abstract][Full Text] [Related]
48. Allergy induced by Parietaria officinalis pollen in southern Croatia.
Cvitanović S; Marusić M; Zekan L; Köhler-Kubelka N
Allergy; 1986 Sep; 41(7):543-5. PubMed ID: 3789335
[TBL] [Abstract][Full Text] [Related]
49. A double-blind, placebo-controlled trial of local nasal immunotherapy in allergic rhinitis to Parietaria pollen.
D'Amato G; Lobefalo G; Liccardi G; Cazzola M
Clin Exp Allergy; 1995 Feb; 25(2):141-8. PubMed ID: 7750006
[TBL] [Abstract][Full Text] [Related]
50. In vitro evaluation of blocking antibodies by RAST interference during pollen desensitization: role of the IgG fraction.
Chien YK; Anfosso F; Vervloet D; Charpin J
Biomed Pharmacother; 1982; 36(3):145-9. PubMed ID: 7150707
[TBL] [Abstract][Full Text] [Related]
51. Measurement of serum levels of eosinophil cationic protein to monitor patients with seasonal respiratory allergy induced by Parietaria pollen (treated and untreated with specific immunotherapy).
D'Amato G; Liccardi G; Russo M; Saggese M; D'Amato M
Allergy; 1996 Apr; 51(4):245-50. PubMed ID: 8792921
[TBL] [Abstract][Full Text] [Related]
52. Immunotherapy for respiratory allergic diseases: indications, efficacy and monitoring.
Negrini AC
Allerg Immunol (Paris); 1993 Dec; 25(10):431-5. PubMed ID: 8155273
[TBL] [Abstract][Full Text] [Related]
53. The perennial pattern of clinical symptoms in children monosensitized to Olea europaea pollen allergens in comparison with subjects with Parietaria and Gramineae pollinosis.
Liccardi G; Russo M; Piccolo A; Lobefalo G; Salzillo A; D'Amato M; D'Amato G
Allergy Asthma Proc; 1997; 18(2):99-105. PubMed ID: 9134068
[TBL] [Abstract][Full Text] [Related]
54. Cross-reactivity between Parietaria judaica and Parietaria officinalis.
Corbi AL; Pelaez A; Errigo E; Carreira J
Ann Allergy; 1985 Feb; 54(2):142-7. PubMed ID: 3970390
[TBL] [Abstract][Full Text] [Related]
55. Diagnosis of inhalant allergy in a chimpanzee using "in vivo" and "in vitro" tests.
Halpern GM; Gershwin LJ; Gonzales G; Fowler ME
Allergol Immunopathol (Madr); 1989; 17(5):271-6. PubMed ID: 2692450
[TBL] [Abstract][Full Text] [Related]
56. Grass pollen hyposensitization versus placebo therapy.
Weyer A; Heritier CL; David B
Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M; 1983; (78):101-7. PubMed ID: 6354089
[No Abstract] [Full Text] [Related]
57. IgG subclass antibodies against Parietaria judaica in normal and allergic subjects.
Palumbo S; Di Felice G; Mari A; Bonini S; Bruno G; Tinghino R; Afferni C; Sallusto F; Pini C
Allergy; 1994 Apr; 49(4):222-9. PubMed ID: 8037355
[TBL] [Abstract][Full Text] [Related]
58. Tolerability and positive efficacy results after subcutaneous immunotherapy with Parietaria judaica depot extract.
Enrique E; de Rojas DH; Alba P; Flores I; Colomer N; Andreu C; Gómez-Fernández MC; Landeta A; Asturias JA; Martínez A; Madariaga-Goirigolzarri B
Immunotherapy; 2018 Oct; 10(14):1253-1263. PubMed ID: 30326788
[TBL] [Abstract][Full Text] [Related]
59. The role of IgG in immediate-type hypersensitivity.
Van der Zee JS; Aalberse RC
Eur Respir J Suppl; 1991 Apr; 13():91s-96s. PubMed ID: 1953922
[TBL] [Abstract][Full Text] [Related]
60. Immunologic changes during specific treatment of the atopic state. 3. The immunologic response in the course of hyposensitization of hay fever patients with aqueous and alum - pyridine allergens.
Zavázal V; Stajner A
Acta Allergol; 1970 Apr; 25(1):18-24. PubMed ID: 5468237
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
